GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Charmacy Pharmaceutical Co Ltd (HKSE:02289) » Definitions » Shiller PE Ratio

Charmacy Pharmaceutical Co (HKSE:02289) Shiller PE Ratio : 17.35 (As of May. 31, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Charmacy Pharmaceutical Co Shiller PE Ratio?

As of today (2024-05-31), Charmacy Pharmaceutical Co's current share price is HK$9.37. Charmacy Pharmaceutical Co's E10 for the fiscal year that ended in Dec23 was HK$0.54. Charmacy Pharmaceutical Co's Shiller PE Ratio for today is 17.35.

The historical rank and industry rank for Charmacy Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

HKSE:02289' s Shiller PE Ratio Range Over the Past 10 Years
Min: 16.05   Med: 20.48   Max: 26.67
Current: 17.35

During the past 10 years, Charmacy Pharmaceutical Co's highest Shiller PE Ratio was 26.67. The lowest was 16.05. And the median was 20.48.

HKSE:02289's Shiller PE Ratio is ranked better than
55.56% of 54 companies
in the Medical Distribution industry
Industry Median: 18.66 vs HKSE:02289: 17.35

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Charmacy Pharmaceutical Co's adjusted earnings per share data of for the fiscal year that ended in Dec23 was HK$0.520. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is HK$0.54 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Charmacy Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Charmacy Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charmacy Pharmaceutical Co Shiller PE Ratio Chart

Charmacy Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 23.91

Charmacy Pharmaceutical Co Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 23.91

Competitive Comparison of Charmacy Pharmaceutical Co's Shiller PE Ratio

For the Medical Distribution subindustry, Charmacy Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charmacy Pharmaceutical Co's Shiller PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Charmacy Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Charmacy Pharmaceutical Co's Shiller PE Ratio falls into.



Charmacy Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Charmacy Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=9.37/0.54
=17.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charmacy Pharmaceutical Co's E10 for the fiscal year that ended in Dec23 is calculated as:

For example, Charmacy Pharmaceutical Co's adjusted earnings per share data for the fiscal year that ended in Dec23 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec23 (Change)*Current CPI (Dec23)
=0.52/114.7809*114.7809
=0.520

Current CPI (Dec23) = 114.7809.

Charmacy Pharmaceutical Co Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 0.571 99.000 0.662
201512 0.388 100.600 0.443
201612 0.586 102.600 0.656
201712 0.491 104.500 0.539
201812 0.478 106.500 0.515
201912 0.414 111.200 0.427
202012 0.445 111.500 0.458
202112 0.263 113.108 0.267
202212 0.935 115.116 0.932
202312 0.520 114.781 0.520

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Charmacy Pharmaceutical Co  (HKSE:02289) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Charmacy Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Charmacy Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Charmacy Pharmaceutical Co (HKSE:02289) Business Description

Traded in Other Exchanges
N/A
Address
No. 235, Song Shan North Road, Longhu District, Guangdong Province, Shantou, CHN, 515041
Charmacy Pharmaceutical Co Ltd is a China-based pharmaceutical distributor. It distributes diversified pharmaceutical products to pharmaceutical distributors, retail pharmacies, hospitals, clinics, and health centers. The company's distribution network covers Southern China and surrounding areas including Fujian province. The firm offers Western medicines, Chinese patent medicines, healthcare products, Chinese medicine material and decoction pieces, medical devices, cosmetic products, and others. All the group's operations are located in China.
Executives
Jiangxi Pharmaceutical Investment Co., Limited 2101 Beneficial owner
Jiang Yao Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Jiang Xi Jiang Zhong Yi Yao Shang Ye Yun Ying You Xian Ze Ren Gong Si 2201 Interest of corporation controlled by you
Yao Chuanglong 2101 Beneficial owner
You Zeyan 2202 Interest of your spouse
Guang Zhou Bai Yun Shan Yi Yao Ji Tuan Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Guang Zhou Yi Yao Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Guang Yao Bai Yun Shan Xiang Gang You Xian Gong Si 2101 Beneficial owner
Rays Capital Partners Limited 2102 Investment manager
Ruan David Ching Chi 2201 Interest of corporation controlled by you
Asian Equity Special Opportunities Portfolio Master Fund Limited 2101 Beneficial owner
Wang Yonghui 2101 Beneficial owner

Charmacy Pharmaceutical Co (HKSE:02289) Headlines

No Headlines